MAPT and Niemann-Pick disease type C: Interestingly, plasma p-tau217 has also been reported as a superior prognostic marker in Alzheimer’s disease when compared with other p-tau species,13,15,18 which may suggest that the dynamic of this marker in Niemann–Pick disease type C and Alzheimer’s disease is remarkably similar.